MARKET
IPO

KLRA

Kailera Therapeutics
KLRA
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-04-17
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-0.02~-0.01
-
-
1.65B~1.89B
-
2026-03-27
Public Filing
View Prospectus
Pending
Offering
Price Range: 14.00~16.00
Shares to be Issued: 33.33M
2026-04-16
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 117.95M
2026-04-17
Listed
No Data
About KLRA
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.

Webull offers Kailera Therapeutics stock information, including NASDAQ: KLRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KLRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KLRA stock methods without spending real money on the virtual paper trading platform.